Sociedad Americana de Hirudoterapia

Treatment of deep cavities using a perforator-based island flap with partial de-epithelization

Case series published in BMC Surg (2018)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Research reportEnsayos clínicosChang JW et al. · BMC surgery, 2018

Abstract

BACKGROUND: The perforator-based island flap is a popular option for defect coverage. In cases with deep cavities, however, the classical island flap may not be a suitable option. By de-epithelization of the peripheral portion of a perforator-based island flap, the distal part of the flap can be used to fill deep spaces, as the flap can be folded and inserted into the spaces. METHODS: From June 2015 to April 2017, 21 cases of deep internal defects were reconstructed with perforator-based island flaps with peripheral de-epithelization. A fasciocutaneous flap was elevated and rotated with the pivot point on the perforator. After performing de-epithelization on the periphery of the flap, the de-epithelized portion of the flap was inserted and anchored into the internal defect. Demographic information about the patients, the size of the defects, the perforators that were used, and complications were recorded. RESULTS: During the follow-up period (mean, 14.2 months) of total 21 cases, no major complications such as flap loss occurred. In 2 cases, a minor complication was observed. Temporary flap congestion was seen in 1 case, and was treated with a short period of leech therapy, and the other case was partial necrosis on the flap margin, which was cured with minimal debridement and conservative treatment. No major problems have occurred, especially on the de-epithelized part of the flap and in the occupied space. CONCLUSIONS: With performing careful procedure, a perforator-based island flap with partial de-epithelization can be a useful option for the surgical treatment of deep cavities. TRIAL REGISTRATION: This study was retrospectively registered in the institutional review board on human subjects research and the ethics committee, Hanyang University Guri Hospital (Institutional Review Board File No. 2018-01-003-002 https://www.e-irb.com:3443/devlpg/nlpgS200.jsp ).

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAdultAgedAged, 80 and overDebridementFemaleHumansMaleMiddle AgedNecrosisPerforator FlapPostoperative ComplicationsPlastic Surgery Procedures

Resumen

21 cases of deep internal-defect reconstruction with perforator-based de-epithelized island flaps. Temporary flap congestion treated with short course of leech therapy. No major complications.

Por qué esto importa para la hirudoterapia

Este estudio revisó 21 casos de reconstrucción de cavidades profundas mediante colgajos en isla basados en perforantes con desepitelización parcial, sin reportar complicaciones mayores durante un seguimiento medio de 14,2 meses. Un caso de congestión temporal del colgajo se trató con un periodo breve de terapia con sanguijuelas, y un caso de necrosis parcial marginal cicatrizó con manejo conservador. Esto resulta relevante para el dominio de la ASH, ya que documenta el uso exitoso de la terapia con sanguijuelas como medida de rescate para la congestión del colgajo en reconstrucción con colgajos en isla basados en perforantes. El matiz honesto es que la aplicación de sanguijuelas fue un evento menor de un solo caso dentro de un estudio sobre técnica quirúrgica, no se proporcionan detalles sobre el protocolo de la sanguijuelación, su duración ni la especie utilizada, y el objetivo principal del resumen es el diseño del colgajo más que los resultados de la hirudoterapia.

Citación

Treatment of deep cavities using a perforator-based island flap with partial de-epithelization.

Chang JW et al. · BMC surgery, 2018

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.